These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37865341)

  • 1. Cortical alterations in relatives of patients with bipolar disorder: A review of magnetic resonance imaging studies.
    Cattarinussi G; Pouya P; Grimaldi DA; Dini MZ; Sambataro F; Brambilla P; Delvecchio G
    J Affect Disord; 2024 Jan; 345():234-243. PubMed ID: 37865341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resting-state functional magnetic resonance imaging alterations in first-degree relatives of individuals with bipolar disorder: A systematic review.
    Cattarinussi G; Heidari-Foroozan M; Jafary H; Mohammadi E; Sambataro F; Ferro A; Barone Y; Delvecchio G
    J Affect Disord; 2024 Nov; 365():321-331. PubMed ID: 39142577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neural Correlates of the Risk for Schizophrenia and Bipolar Disorder: A Meta-analysis of Structural and Functional Neuroimaging Studies.
    Cattarinussi G; Kubera KM; Hirjak D; Wolf RC; Sambataro F
    Biol Psychiatry; 2022 Sep; 92(5):375-384. PubMed ID: 35523593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Larger right inferior frontal gyrus volume and surface area in participants at genetic risk for bipolar disorders.
    Drobinin V; Slaney C; Garnham J; Propper L; Uher R; Alda M; Hajek T
    Psychol Med; 2019 Jun; 49(8):1308-1315. PubMed ID: 30058502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neural signatures of the risk for bipolar disorder: A meta-analysis of structural and functional neuroimaging studies.
    Cattarinussi G; Di Giorgio A; Wolf RC; Balestrieri M; Sambataro F
    Bipolar Disord; 2019 May; 21(3):215-227. PubMed ID: 30444299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cortical abnormalities in bipolar disorder: an MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working Group.
    Hibar DP; Westlye LT; Doan NT; Jahanshad N; Cheung JW; Ching CRK; Versace A; Bilderbeck AC; Uhlmann A; Mwangi B; Krämer B; Overs B; Hartberg CB; Abé C; Dima D; Grotegerd D; Sprooten E; Bøen E; Jimenez E; Howells FM; Delvecchio G; Temmingh H; Starke J; Almeida JRC; Goikolea JM; Houenou J; Beard LM; Rauer L; Abramovic L; Bonnin M; Ponteduro MF; Keil M; Rive MM; Yao N; Yalin N; Najt P; Rosa PG; Redlich R; Trost S; Hagenaars S; Fears SC; Alonso-Lana S; van Erp TGM; Nickson T; Chaim-Avancini TM; Meier TB; Elvsåshagen T; Haukvik UK; Lee WH; Schene AH; Lloyd AJ; Young AH; Nugent A; Dale AM; Pfennig A; McIntosh AM; Lafer B; Baune BT; Ekman CJ; Zarate CA; Bearden CE; Henry C; Simhandl C; McDonald C; Bourne C; Stein DJ; Wolf DH; Cannon DM; Glahn DC; Veltman DJ; Pomarol-Clotet E; Vieta E; Canales-Rodriguez EJ; Nery FG; Duran FLS; Busatto GF; Roberts G; Pearlson GD; Goodwin GM; Kugel H; Whalley HC; Ruhe HG; Soares JC; Fullerton JM; Rybakowski JK; Savitz J; Chaim KT; Fatjó-Vilas M; Soeiro-de-Souza MG; Boks MP; Zanetti MV; Otaduy MCG; Schaufelberger MS; Alda M; Ingvar M; Phillips ML; Kempton MJ; Bauer M; Landén M; Lawrence NS; van Haren NEM; Horn NR; Freimer NB; Gruber O; Schofield PR; Mitchell PB; Kahn RS; Lenroot R; Machado-Vieira R; Ophoff RA; Sarró S; Frangou S; Satterthwaite TD; Hajek T; Dannlowski U; Malt UF; Arolt V; Gattaz WF; Drevets WC; Caseras X; Agartz I; Thompson PM; Andreassen OA
    Mol Psychiatry; 2018 Apr; 23(4):932-942. PubMed ID: 28461699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of polygenic risk scores for major depressive disorder, bipolar disorder and schizophrenia on morphological brain measures: A systematic review of the evidence.
    Cattarinussi G; Delvecchio G; Sambataro F; Brambilla P
    J Affect Disord; 2022 Aug; 310():213-222. PubMed ID: 35533776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predominant polarity as a neurobiological specifier in bipolar disorder: Evidence from a multimodal neuroimaging study.
    Argyropoulos GD; Christidi F; Karavasilis E; Bede P; Antoniou A; Velonakis G; Seimenis I; Kelekis N; Smyrnis N; Papakonstantinou O; Efstathopoulos E; Ferentinos P
    Prog Neuropsychopharmacol Biol Psychiatry; 2023 Apr; 123():110718. PubMed ID: 36634808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormalities in left inferior frontal gyral thickness and parahippocampal gyral volume in young people at high genetic risk for bipolar disorder.
    Roberts G; Lenroot R; Frankland A; Yeung PK; Gale N; Wright A; Lau P; Levy F; Wen W; Mitchell PB
    Psychol Med; 2016 Jul; 46(10):2083-96. PubMed ID: 27067698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cortical thickness abnormalities in patients with bipolar disorder: A systematic review and meta-analysis.
    Zhu Z; Zhao Y; Wen K; Li Q; Pan N; Fu S; Li F; Radua J; Vieta E; Kemp GJ; Biswa BB; Gong Q
    J Affect Disord; 2022 Mar; 300():209-218. PubMed ID: 34971699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bipolar II disorder is associated with thinning of prefrontal and temporal cortices involved in affect regulation.
    Elvsåshagen T; Westlye LT; Bøen E; Hol PK; Andreassen OA; Boye B; Malt UF
    Bipolar Disord; 2013 Dec; 15(8):855-64. PubMed ID: 23980618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortical thickness and subcortical volumes alterations in euthymic bipolar I patients treated with different mood stabilizers.
    Li L; Ji E; Han X; Tang F; Bai Y; Peng D; Fang Y; Zhang S; Zhang Z; Yang H
    Brain Imaging Behav; 2019 Oct; 13(5):1255-1264. PubMed ID: 30145720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher Levels of C-reactive Protein Are Associated With Higher Cortical Surface Area and Lower Cortical Thickness in Youth With Bipolar Disorder.
    Shao S; Zou Y; Kennedy KG; Dimick MK; MacIntosh BJ; Goldstein BI
    Int J Neuropsychopharmacol; 2023 Dec; 26(12):867-878. PubMed ID: 37947206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased cortical gyrification in patients with bipolar disorder.
    Choi KW; Han KM; Kim A; Kang W; Kang Y; Tae WS; Ham BJ
    Psychol Med; 2022 Sep; 52(12):2232-2244. PubMed ID: 33190651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cortical Volume and Thickness Across Bipolar Disorder Subtypes in Adolescents: A Preliminary Study.
    Toma S; Islam AH; Metcalfe AWS; Mitchell RHB; Fiksenbaum L; MacIntosh BJ; Goldstein BI
    J Child Adolesc Psychopharmacol; 2019 Mar; 29(2):141-151. PubMed ID: 30359542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common and Specific Abnormalities in Cortical Thickness in Patients with Major Depressive and Bipolar Disorders.
    Niu M; Wang Y; Jia Y; Wang J; Zhong S; Lin J; Sun Y; Zhao L; Liu X; Huang L; Huang R
    EBioMedicine; 2017 Feb; 16():162-171. PubMed ID: 28109831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cortical thickness abnormalities in bipolar disorder patients with a lifetime history of auditory hallucinations.
    Mørch-Johnsen L; Nerland S; Jørgensen KN; Osnes K; Hartberg CB; Andreassen OA; Melle I; Nesvåg R; Agartz I
    Bipolar Disord; 2018 Nov; 20(7):647-657. PubMed ID: 29441665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerated cortical thinning and volume reduction over time in young people at high genetic risk for bipolar disorder.
    Roberts G; Lenroot R; Overs B; Fullerton J; Leung V; Ridgway K; Stuart A; Frankland A; Levy F; Hadzi-Pavlovic D; Breakspear M; Mitchell PB
    Psychol Med; 2022 May; 52(7):1344-1355. PubMed ID: 32892764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gray matter abnormalities as brain structural vulnerability factors for bipolar disorder: A review of neuroimaging studies of individuals at high genetic risk for bipolar disorder.
    Nery FG; Monkul ES; Lafer B
    Aust N Z J Psychiatry; 2013 Dec; 47(12):1124-35. PubMed ID: 23864160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased cortical surface area but not altered cortical thickness or gyrification in bipolar disorder following stabilisation from a first episode of mania.
    Van Rheenen TE; Cotton SM; Dandash O; Cooper RE; Ringin E; Daglas-Georgiou R; Allott K; Chye Y; Suo C; Macneil C; Hasty M; Hallam K; McGorry P; Fornito A; Yücel M; Pantelis C; Berk M
    Prog Neuropsychopharmacol Biol Psychiatry; 2023 Mar; 122():110687. PubMed ID: 36427550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.